Spectral Med Operating Income Over Time
| EDT Stock | CAD 1.38 0.03 2.22% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Spectral Med Performance and Spectral Med Correlation. Spectral |
Cross Equities Operating Income Analysis
Compare Spectral Med and related stocks such as High Tide, Cipher Pharmaceuticals, and Aurora Cannabis Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HITI | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 958.8 K | (3.7 M) | (19.6 M) | (677 K) | (18.7 M) | (20.1 M) | (41.4 M) | 15.3 M | 15.4 M | 17.8 M | 18.6 M |
| CPH | (6 M) | (2.4 M) | 2.4 M | 17.1 M | (4.8 M) | (68 K) | (31.8 M) | 25.2 M | 5.3 M | 11.7 M | 12.2 M | 11.8 M | 12 M | 11.5 M | 7.8 M | 9 M | 9.5 M |
| ACB | (1.2 K) | (330.8 K) | (402.9 K) | (306.5 K) | (4.4 M) | (4.6 M) | (11.2 M) | (95.8 M) | (318.3 M) | (465.8 M) | (282.8 M) | (231.4 M) | (254.3 M) | (46.5 M) | 4.9 M | 4.5 M | 4.7 M |
| FRX | (1.6 M) | (3.4 M) | (3.6 M) | (1.9 M) | (2.9 M) | (1.9 M) | (2.9 M) | (7 M) | (10.4 M) | (13 M) | (17.9 M) | (17.2 M) | (22.6 M) | (12.8 M) | 2.6 M | 2.3 M | 2.4 M |
| WEED | (26.9 K) | (21.4 K) | (64.6 K) | (931.7 K) | (6.7 M) | (2.7 M) | (14.1 M) | (119.6 M) | (637.5 M) | (1.7 B) | (1.2 B) | (1 B) | (2.6 B) | (228.7 M) | (117.1 M) | (6.7 M) | (7.1 M) |
| EPRX | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (14.3 M) | (6.1 M) | (2.2 M) | (20.9 M) | (22.6 M) | (36.9 M) | (37 M) | (33.3 M) | (31.6 M) |
| KSI | (49.7 M) | (49.7 M) | (49.7 M) | (49.7 M) | (1 M) | (2.1 M) | (2.6 M) | (654.3 K) | (5.2 M) | (5 M) | (6.6 M) | (6.4 M) | (9.8 M) | (13.5 M) | (5.9 M) | (6.8 M) | (7.2 M) |
| PRN | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (11.2 M) | (15.6 M) | (17.6 M) | (14.8 M) | (15.1 M) | (18.9 M) | (30.3 M) | (29.6 M) | (28.6 M) | (33.1 M) | (29.8 M) | (31.2 M) |
Spectral Med and related stocks such as High Tide, Cipher Pharmaceuticals, and Aurora Cannabis Operating Income description
Operating Income is the amount of profit realized from Spectral Med operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Spectral Med is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Spectral Med | EDT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 135 The West |
| Exchange | Toronto Exchange |
CAD 1.38
Other Information on Investing in Spectral Stock
Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.